Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Braveheart Bio, Inc. (BRVE) since 2026 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Braveheart Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 2131524.
Total stock buying since 2026: $159,034,950.
Total stock sales since 2026: $0.
Total stock option exercises since 2026: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2026 | 8,835,275 | $159,034,950 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2026-08 | 8,835,275 | $159,034,950 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-08-07 | Forbion Ventures Vii Management B.v. | Buy | 3,600,000 | 18.00 | 64,800,000 |
| 2026-08-07 | Anderson Michele A. (Chief Development Officer) | Buy | 1,111 | 18.00 | 19,998 |
| 2026-08-07 | Malek David I (Director) | Buy | 4,166 | 18.00 | 74,988 |
| 2026-08-07 | Murdoch Travis (CEO and President) | Buy | 83,333 | 18.00 | 1,499,994 |
| 2026-08-07 | Orbimed Genesis Gp Llc | Buy | 1,940,000 | 18.00 | 34,920,000 |
| 2026-08-07 | Viehbacher Christopher (Director) | Buy | 83,333 | 18.00 | 1,499,994 |
| 2026-08-07 | Chimovits Erez | Buy | 1,940,000 | 18.00 | 34,920,000 |
| 2026-08-07 | Rickey James Paul (Chief Financial Officer) | Buy | 27,777 | 18.00 | 499,986 |
| 2026-08-07 | Lubner David Charles (Director) | Buy | 55,555 | 18.00 | 999,990 |
| 2026-08-07 | Horowitz Benjamin A | Buy | 1,100,000 | 18.00 | 19,800,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of BRVE listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Braveheart Bio, Inc. (symbol BRVE, CIK number 2131524) see the Securities and Exchange Commission (SEC) website.